Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Autoimmune Disorders

  Free Subscription


3 Brain
1 J Autoimmun
1 J Neuroimmunol
7 J Neurol
4 Kidney Int
13 Mult Scler
3 N Engl J Med
2 Nat Rev Neurol
2 Neurol Clin Pract
2 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    PubMed         Abstract available

  2. JAMANN H, Desu HL, Cui QL, Halaweh A, et al
    ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
    Brain. 2024;147:147-162.
    PubMed         Abstract available

    Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA.
    Brain. 2024 Jan 5:awae006. doi: 10.1093.

    J Autoimmun

  4. LI Y, Tang C, Vanarsa K, Thai N, et al
    Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    J Autoimmun. 2024;143:103165.
    PubMed         Abstract available

    J Neuroimmunol

  5. PETERSEN-CHERUBINI CL, Liu Y, Deffenbaugh JL, Murphy SP, et al
    Dysregulated autotaxin expression by T cells in multiple sclerosis.
    J Neuroimmunol. 2024;387:578282.
    PubMed         Abstract available

    J Neurol

  6. FAVRUZZO F, Palmieri A, Giopato F, Cardellini D, et al
    Subacute transverse myelitis of possible vasculitic origin after SARS-CoV2 and Varicella-Zoster virus infections: a case report.
    J Neurol. 2024;271:75-78.

  7. NEUMANN B, Angstwurm K, Dohmen C, Mergenthaler P, et al
    Weaning and extubation failure in myasthenic crisis: a multicenter analysis.
    J Neurol. 2024;271:564-574.
    PubMed         Abstract available

  8. WIESENFARTH M, Stamminger T, Zizer E, Tumani H, et al
    Neurological manifestation of HEV infection: still a rare disease entity?
    J Neurol. 2024;271:386-394.
    PubMed         Abstract available

  9. MOSER T, Zimmermann G, Baumgartner A, Berger T, et al
    Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study.
    J Neurol. 2024;271:374-385.
    PubMed         Abstract available

  10. KUMPFEL T, Giglhuber K, Aktas O, Ayzenberg I, et al
    Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
    J Neurol. 2024;271:141-176.
    PubMed         Abstract available

  11. ZHENG P, Sandroff BM, Motl RW
    Free-living ambulatory physical activity and cognitive function in multiple sclerosis: the significance of step rate vs. step volume.
    J Neurol. 2024 Jan 12. doi: 10.1007/s00415-023-12169.
    PubMed         Abstract available

  12. MAILLART E, Todesco E, Assoumou L, Beigneux Y, et al
    Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
    J Neurol. 2024 Jan 11. doi: 10.1007/s00415-023-12175.

    Kidney Int

  13. LUCIENTES-CONTINENTE L, Fernandez-Juarez G, Marquez-Tirado B, Jimenez-Villegas L, et al
    Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Kidney Int. 2024;105:177-188.
    PubMed         Abstract available

  14. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.
    Kidney Int. 2024;105.

  15. FLOEGE J
    A new alternative: inhibiting complement activation in patients with IgA nephropathy.
    Kidney Int. 2024;105:28-30.
    PubMed         Abstract available

  16. ROVIN BH, Ayoub IM, Chan TM, Liu ZH, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis.
    Kidney Int. 2024;105:31-34.
    PubMed         Abstract available

    Mult Scler

  17. WRIGHT SL, Thompson AJ
    Managing patients with late-onset neutropenia during treatment with ocrelizumab.
    Mult Scler. 2024;30:134.

  18. GUO RY, Wang WY, Huang JY, Jia Z, et al
    Deciphering prognostic indicators in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder: An integrative review of demographic and laboratory factors.
    Mult Scler. 2024;30:7-15.
    PubMed         Abstract available

  19. DE GIER M, Beckerman H, Twisk JW, Knoop H, et al
    Effectiveness of a blended booster programme for the long-term outcome of cognitive behavioural therapy for MS-related fatigue: A randomized controlled trial.
    Mult Scler. 2024;30:71-79.
    PubMed         Abstract available

  20. HUGOS CL, Joos SK, Perumean-Chaney SE, Cutter GR, et al
    Stretching is not essential for managing MS spasticity: A randomized controlled trial.
    Mult Scler. 2024;30:89-102.
    PubMed         Abstract available

  21. KOCH-HENRIKSEN NI, Thygesen LC, Sorensen PS, Magyari M, et al
    Using instrumental variables to correct for bias in real-world cohort studies of the effects of disease-modifying treatment in MS.
    Mult Scler. 2024;30:113-120.
    PubMed         Abstract available

  22. PORTACCIO E, Iaffaldano P
    Maternal smoking and multiple sclerosis risk in offspring: A further clue of prenatal environmental triggers.
    Mult Scler. 2024 Jan 11:13524585231224667. doi: 10.1177/13524585231224667.

  23. FRAMKE E, Thygesen LC, Malmborg M, Schou M, et al
    Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark.
    Mult Scler. 2024 Jan 11:13524585231221415. doi: 10.1177/13524585231221415.
    PubMed         Abstract available

  24. MOTYL J
    Advancing assessment of cognitive change in multiple sclerosis: Seeking valid and sensitive approaches beyond simple cut-offs.
    Mult Scler. 2024 Jan 9:13524585231221409. doi: 10.1177/13524585231221409.

  25. VAN LAETHEM D, Denissen S, Costers L, Descamps A, et al
    The Finger Dexterity Test: Validation study of a smartphone-based manual dexterity assessment.
    Mult Scler. 2024;30:121-130.
    PubMed         Abstract available

  26. MARIGNIER R, Cree BA
    MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: No.
    Mult Scler. 2024;30:21-23.

  27. CARNERO CONTENTTI E, Wingerchuk DM
    MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.
    Mult Scler. 2024;30:19-21.

    MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Commentary.
    Mult Scler. 2024;30:23-24.

    Response to letter to the editor "Advancing assessment of cognitive change in multiple sclerosis: Seeking valid and sensitive approaches beyond simple cut-offs".
    Mult Scler. 2024 Jan 9:13524585231221412. doi: 10.1177/13524585231221412.

    N Engl J Med

  30. LEE TTM, Bergford S, Murphy HR
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:184.

  31. GRZYCH G, Kim I
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183-184.

  32. VIVANTI AJ, Benachi A, Voican A
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183.

    Nat Rev Neurol

  33. IORIO R
    Myasthenia gravis: the changing treatment landscape in the era of molecular therapies.
    Nat Rev Neurol. 2024 Jan 8. doi: 10.1038/s41582-023-00916.
    PubMed         Abstract available

  34. KIANI L
    Improved quality of life with MS treatment.
    Nat Rev Neurol. 2024;20:1.

    Neurol Clin Pract

  35. GANDELMAN S, Lenzi KA, Markowitz C, Berger JR, et al
    A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy.
    Neurol Clin Pract. 2024;14:e200241.
    PubMed         Abstract available

  36. NGUYEN M, Clough M, Cruse B, van der Walt A, et al
    Exploring Factors That Prolong the Diagnosis of Myasthenia Gravis.
    Neurol Clin Pract. 2024;14:e200244.
    PubMed         Abstract available


  37. NG HS, Zhu F, Zhao Y, Yao S, et al
    Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis.
    Neurology. 2024;102:e208006.
    PubMed         Abstract available

  38. ALKABIE S, Gray MT, Lau JC, Barra L, et al
    Teaching NeuroImage: Unilateral Primary Angiitis of the CNS.
    Neurology. 2024;102:e208018.
    PubMed         Abstract available

    PLoS One

  39. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  40. GOTTLIEB A, Pham HPT, Saltarrelli JG, Lindsey JW, et al
    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.
    Proc Natl Acad Sci U S A. 2024;121:e2315857121.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.